-0.10 | -0.22%
| Price and Volume | |
|---|---|
| Recent Price | 44.82 |
| 52 Week High | 60.35 |
| 52 Week Low | 36.55 |
| Avg. Daily Vol. (Mil) | 0.72 |
| Beta (3 year) | 1.43 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,406.20 |
| Shares Out (Mil) | 53.69 |
| Float (Mil) | 52.95 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.80 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 0.26 |
| Total Debt / Equity | 0.26 |
| Valuation Ratios | |
| Price Earnings | 9.50 |
| Price/Sales | 3.07 |
| Price/Book | 2.35 |
| Price/Cash Flow | 7.60 |
| Per Share Data | |
| Earnings | 4.71 |
| Sales | 14.62 |
| Book Value | 19.09 |
| Cash Flow | 5.88 |
| Business Summary | |
|---|---|
| United Therapeutics Corporation is a biotechnology company, which is focused on the development and commercialization of products to address the medical needs of patients with chronic and life-threatening conditions. | |
| General Information | |
| 1040 Spring Street
Silver Spring, MD 20910 |
|
| www.unither.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 543 | |
| CEO: Martine A. Rothblatt,PhD | |
| Short Interest | |
| Current Month (Mil) | 3.05 |
| Previous Month (Mil) | 2.98 |
| Short Interest Ratio (Days) | 3.60 |
| Management Effectiveness | |
| Return on Equity | 26.60 |
| Return on Assets | 17.40 |
| Return on Investments | 21.10 |
| Profitability | |
| Gross Margin | 93.70 |
| EBIT Margin | 49.90 |
| Profit Margin | 34.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet